<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01396941</url>
  </required_header>
  <id_info>
    <org_study_id>K23HL096832</org_study_id>
    <secondary_id>K23HL096832</secondary_id>
    <nct_id>NCT01396941</nct_id>
  </id_info>
  <brief_title>Effects of Sleep Duration and Architecture on Insulin Sensitivity</brief_title>
  <official_title>Effects of Sleep Duration and Architecture on Insulin Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot clinical trial will test the hypotheses that sleep restriction (for 5 nights), in&#xD;
      comparison to &quot;normal sleep&quot;, will:&#xD;
&#xD;
        1. Decrease peripheral insulin sensitivity and glucose tolerance, as measured by the&#xD;
           hyperinsulinemic-euglycemic clamp and oral glucose tolerance test.&#xD;
&#xD;
        2. Decrease hepatic insulin sensitivity, as assessed by stable isotope studies of&#xD;
           endogenous glucose production, gluconeogenesis and glycogenolysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the past 50 years, the incidence of diabetes has increased dramatically, while sleep&#xD;
      duration in the US has decreased significantly. Epidemiological studies and small clinical&#xD;
      trials suggest that these trends are causally related. In this study, our goal is to&#xD;
      determine the mechanisms by which decreased sleep duration directly affects insulin&#xD;
      sensitivity. The investigators will perform a clinical study in 20 healthy volunteers to&#xD;
      determine whether 5 nights of sleep restriction decreases insulin sensitivity in the&#xD;
      peripheral tissues (ie, skeletal muscle) or liver.&#xD;
&#xD;
      Peripheral insulin sensitivity will be measured by the hyperinsulinemic-euglycemic clamp, and&#xD;
      hepatic insulin sensitivity will be quantified by measurement of hepatic glucose production,&#xD;
      gluconeogenesis and glycogenolysis (using stable isotope tracer methods). Subjects will be&#xD;
      randomized to an initial period of &quot;normal sleep&quot; or sleep restriction and will be admitted&#xD;
      to the Clinical Research Center (CRC) for 9 days to undergo comprehensive metabolic studies&#xD;
      and sleep assessments under the assigned sleep condition. After a 1-month washout period,&#xD;
      subjects will be re-admitted to the CRC to undergo these same assessments under the opposite&#xD;
      sleep condition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>1 month</time_frame>
    <description>Peripheral insulin sensitivity will be measured using the hyperinsulinemic-euglycemic clamp. Hepatic insulin sensitivity will be measured using stable isotope tracer studies.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>sleep restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators will compare the effects of sleep restriction vs. normal sleep in healthy volunteers, using a randomized crossover study design. Each subject will undergo a period of normal sleep and a period of sleep restriction, separated by a 1-month washout period. Subjects will be randomized to receive either sleep restriction first (later followed by normal sleep) or normal sleep first (later followed by sleep restriction).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep restriction</intervention_name>
    <description>Sleep restriction will consist of 5 nights, sleeping 4 hours per night Normal sleep will consist of 5 nights, sleeping 9 hours per night</description>
    <arm_group_label>sleep restriction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-45 years&#xD;
&#xD;
          -  Regular work hours (ie, no night-time or shift work within the past 6 months)&#xD;
&#xD;
          -  Pittsburgh Sleep Quality Index (PSQI) Score &lt;5&#xD;
&#xD;
          -  Average nightly sleep duration 6-9 hours (per screening actigraphy)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or prior diabetes, gestational diabetes, impaired glucose tolerance or&#xD;
             impaired fasting glucose&#xD;
&#xD;
          -  Type 2 diabetes in biological parents&#xD;
&#xD;
          -  BMI &gt;=25&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Chronic medical condition, including: psychiatric disorders, heart disease, pulmonary&#xD;
             disease, infectious diseases, rheumatological and neurological disorders&#xD;
&#xD;
          -  Use of prescribed medications on a regular basis.&#xD;
&#xD;
          -  History of disorder involving hypothalamic, pituitary or adrenal glands&#xD;
&#xD;
          -  History of or current sleep disorders (insomnia, restless leg syndrome, sleep&#xD;
             disordered breathing, narcolepsy, etc)&#xD;
&#xD;
          -  Anemia&#xD;
&#xD;
          -  Cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Madhu N. Rao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 15, 2011</study_first_submitted>
  <study_first_submitted_qc>July 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2011</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

